A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch Allergy
NCT07710846 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2026-07-17
Summary
The purpose of this Patient Identification and Characterization (PIC) study is to collect information and perform limited allergy-related procedures to determine if participants can qualify for cat and/or birch tree pollen allergy clinical research studies in the future. The study is also looking at how cat and/or birch tree pollen allergies have affected overall health.
Conditions
- Conjunctivitis Allergic
Interventions
- OTHER
-
Noninterventional
No investigational medicinal products will be administered in this study.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trial Management · Regeneron Pharmaceuticals
Eligibility
- Min Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-17
- Primary Completion
- 2028-01-10
- Completion
- 2028-01-10
More Related Trials
-
Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch
NCT01902992 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis
NCT00309062 ·Status: COMPLETED ·Phase: PHASE3
-
Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis
NCT01383590 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy
NCT06602726 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
NCT04981717 ·Status: TERMINATED ·Phase: PHASE3
-
S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch Pollen
NCT04912076 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy
NCT06602739 ·Status: COMPLETED ·Phase: PHASE3
-
Conjunctival Allergen Challenge (CAC) Following Allergen Exposure in the Allergen BioCube (ABC)
NCT00985296 ·Status: COMPLETED
-
Open Label Safety Study of a Birch Pollen Allergen Extract
NCT00818181 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00575003 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
NCT01144429 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma
NCT00867906 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens
NCT00263627 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.
NCT07155499 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis
NCT01731249 ·Status: COMPLETED ·Phase: PHASE3
-
Study of DM-101PX in Adults With Birch Pollen Allergy
NCT07254871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis
NCT01383603 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen
NCT01728519 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis
NCT04878354 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
NCT03290248 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis
NCT01490411 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy
NCT02745418 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Validation Study in Allergic Conjunctivitis to Birch Pollen During Allergen Challenge in ALYATEC EEC
NCT04641130 ·Status: COMPLETED ·Phase: NA
-
Sensitivity and Specificity of 3 Solutions of Allergen Extract for Diagnosis by Skin Prick Testing
NCT01964768 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BLU-808 in Allergic Rhinoconjunctivitis
NCT06922448 ·Status: COMPLETED ·Phase: PHASE2